Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis

Clinical trial NCT02145923 · UNKNOWN

Trial details

NCT number: NCT02145923
Sponsor: Burnasyan Federal Medical Biophysical Center
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neutropenic Enterocolitis Myeloablative Chemotherapy Induced Bone Marrow Aplasia

Start date: 2014-05-01
Primary completion: 2016-06-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.